Lithuania

Last Updated 24 September 2021.

4 Vaccines Approved for Use in Lithuania

• Moderna
  mRNA-1273

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 72 countries

  28 trials in 2 countries

  Approval Source: cnn.com

  RNA

• Pfizer/BioNTech
  BNT162b2

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 100 countries

  33 trials in 16 countries

  Approval Source: pfizer.com

  RNA

• Janssen (Johnson & Johnson)
  Ad26.COV2.S

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 66 countries

  10 trials in 16 countries

  Approval Source: nytimes.com

  Non Replicating Viral Vector

• Oxford/AstraZeneca
  AZD1222

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 122 countries

  40 trials in 2 countries

  Approval Source: ema.europa.eu

  Non Replicating Viral Vector

0 Vaccines in Clinical Trials in Lithuania